Class IITerminatedD-0265-2022
Drug recall · December 8, 2021
5% Dextrose Injection recall
Why: Lack of sterility assurance: bag has the potential to leak.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
5% Dextrose Injection, USP, 50 mL ADD-Vantage Unit, Rx only, Distributed by Hospira, INC., Lake Forest, IL 60045 USA, NDC 0409-7100-68/0409-7100-66
- Lots / codes
Lot: 4923608 Exp. 1MAY2022
- Quantity
- 765 bags
- Company
- Pfizer Inc., New York, NY
- Distribution
- USA Nationwide
- Initiated
- November 30, 2021 · Voluntary: Firm initiated
- Classified
- December 2, 2021
- Reported
- December 8, 2021
- Ended
- July 12, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.